Clinical Trial Update: Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis [NA]

View source ↗

Summary

A clinical trial assessing sodium chloride 6.0% sino-nasal inhalation in patients with cystic fibrosis and chronic rhinosinusitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Rhinosinusitis

Drugs mentioned

• Sodium chloride 6.0% sino-nasal inhalation (sodium chloride 6.0%)

Snippet

Sponsor: University of Jena | Conditions: Cystic Fibrosis, Rhinosinusitis | NA | Status: COMPLETED